FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes | Business Wire

This seems like good news. Whether it will be available for lower income people through medicare/medicaid would mean a lot to help them monitor their glucose levels.

FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes
— Read on www.businesswire.com/news/home/20180327006343/en/FDA-Authorizes-Marketing-New-Dexcom-G6®-CGM